Literature DB >> 24022302

Functional analysis of 11 novel GBA alleles.

Erika Malini1, Serena Grossi2, Marta Deganuto1, Camillo Rosano3, Rossella Parini4, Silvia Dominisini1, Roberta Cariati1, Stefania Zampieri1, Bruno Bembi1, Mirella Filocamo2, Andrea Dardis1.   

Abstract

Gaucher disease is the most frequent lysosomal storage disorder due to the deficiency of the acid β-glucosidase, encoded by the GBA gene. In this study, we report the structural and functional characterization of 11 novel GBA alleles. Seven single missense alleles, P159S, N188I, E235K, P245T, W312S, S366R and W381C, and two alleles carrying in cis mutations, (N188S; G265R) and (E326K; D380N), were studied for enzyme activity in transiently transfected cells. All mutants were inactive except the P159S, which retained 15% of wild-type activity. To further characterize the alleles carrying two in cis mutations, we expressed constructs bearing singly each mutation. The presence of G265R or D380N mutations completely abolished enzyme activity, while N188S and E326K mutants retained 25 and 54% of wild-type activity, respectively. Two mutations, affecting the acceptor splice site of introns 5 (c.589-1G>A) and 9 (c.1389-1G>A), led to the synthesis of aberrant mRNA. Unpredictably, family studies showed that two alleles resulted from germline or 'de novo' mutations. These results strengthen the importance of performing a complete and accurate molecular analysis of the GBA gene in order to avoid misleading conclusions and provide a comprehensive functional analysis of new GBA mutations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24022302      PMCID: PMC3953908          DOI: 10.1038/ejhg.2013.182

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  27 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  Somatic mosaicism in a patient with Gaucher disease type 2: implication for genetic counseling and therapeutic decision-making.

Authors:  M Filocamo; G Bonuccelli; R Mazzotti; F Corsolini; M Stroppiano; S Regis; R Gatti
Journal:  Blood Cells Mol Dis       Date:  2000-12       Impact factor: 3.039

3.  Standardizing mutation nomenclature: why bother?

Authors:  Johan T den Dunnen; Mark H Paalman
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

4.  Improved splice site detection in Genie.

Authors:  M G Reese; F H Eeckman; D Kulp; D Haussler
Journal:  J Comput Biol       Date:  1997       Impact factor: 1.479

5.  Biosynthesis of the lysosomal enzyme glucocerebrosidase.

Authors:  A H Erickson; E I Ginns; J A Barranger
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

6.  Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.

Authors:  V Koprivica; D L Stone; J K Park; M Callahan; A Frisch; I J Cohen; N Tayebi; E Sidransky
Journal:  Am J Hum Genet       Date:  2000-05-04       Impact factor: 11.025

7.  Identification and functional characterization of five novel mutant alleles in 58 Italian patients with Gaucher disease type 1.

Authors:  Snjezana Miocić; Mirella Filocamo; Silvia Dominissini; Anna Lisa E Montalvo; Kristian Vlahovicek; Marta Deganuto; Raffaella Mazzotti; Roberta Cariati; Bruno Bembi; Maria Gabriela Pittis
Journal:  Hum Mutat       Date:  2005-01       Impact factor: 4.878

8.  Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian gaucher patients.

Authors:  Mirella Filocamo; Raffaella Mazzotti; Marina Stroppiano; Marco Seri; Fiorina Giona; Giancarlo Parenti; Stefano Regis; Fabio Corsolini; Stefania Zoboli; Rosanna Gatti
Journal:  Hum Mutat       Date:  2002-09       Impact factor: 4.878

9.  LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.

Authors:  David Reczek; Michael Schwake; Jenny Schröder; Heather Hughes; Judith Blanz; Xiaoying Jin; William Brondyk; Scott Van Patten; Tim Edmunds; Paul Saftig
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

10.  Expression and functional characterization of mutated glucocerebrosidase alleles causing Gaucher disease in Spanish patients.

Authors:  Pilar Alfonso; José Carlos Rodríguez-Rey; Alberto Gañán; Juan Ignacio Pérez-Calvo; Manuel Giralt; Pilar Giraldo; Miguel Pocoví
Journal:  Blood Cells Mol Dis       Date:  2004 Jan-Feb       Impact factor: 3.039

View more
  17 in total

1.  LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's disease.

Authors:  Maria Kedariti; Emanuele Frattini; Pascale Baden; Susanna Cogo; Laura Civiero; Elena Ziviani; Gianluca Zilio; Federico Bertoli; Massimo Aureli; Alice Kaganovich; Mark R Cookson; Leonidas Stefanis; Matthew Surface; Michela Deleidi; Alessio Di Fonzo; Roy N Alcalay; Hardy Rideout; Elisa Greggio; Nicoletta Plotegher
Journal:  NPJ Parkinsons Dis       Date:  2022-07-19

Review 2.  Glucocerebrosidase is shaking up the synucleinopathies.

Authors:  Marina Siebert; Ellen Sidransky; Wendy Westbroek
Journal:  Brain       Date:  2014-02-14       Impact factor: 13.501

3.  Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies.

Authors:  Joshua T Geiger; Jinhui Ding; Barbara Crain; Olga Pletnikova; Christopher Letson; Ted M Dawson; Liana S Rosenthal; Alexander Pantelyat; J Raphael Gibbs; Marilyn S Albert; Dena G Hernandez; Argye E Hillis; David J Stone; Andrew B Singleton; John A Hardy; Juan C Troncoso; Sonja W Scholz
Journal:  Neurobiol Dis       Date:  2016-06-14       Impact factor: 5.996

4.  Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.

Authors:  Ganqiang Liu; Brendon Boot; Joseph J Locascio; Iris E Jansen; Sophie Winder-Rhodes; Shirley Eberly; Alexis Elbaz; Alexis Brice; Bernard Ravina; Jacobus J van Hilten; Florence Cormier-Dequaire; Jean-Christophe Corvol; Roger A Barker; Peter Heutink; Johan Marinus; Caroline H Williams-Gray; Clemens R Scherzer
Journal:  Ann Neurol       Date:  2016-11       Impact factor: 10.422

Review 5.  The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions.

Authors:  Tatiana Orme; Rita Guerreiro; Jose Bras
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-10       Impact factor: 5.081

6.  Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.

Authors:  Diego Sucunza; Alberto J Rico; Elvira Roda; María Collantes; Gloria González-Aseguinolaza; Ana I Rodríguez-Pérez; Iván Peñuelas; Alfonso Vázquez; José L Labandeira-García; Vania Broccoli; José L Lanciego
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

7.  Identification of novel splice site mutation IVS9 + 1(G > A) and novel complex allele G355R/R359X in Type 1 Gaucher patients heterozygous for mutation N370S.

Authors:  Kourtnee Hoitsema; Dominick Amato; Aneal Khan; Sandra Sirrs; Francis Y M Choy
Journal:  Meta Gene       Date:  2016-03-23

8.  Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India.

Authors:  Jayesh Sheth; Dhairya Pancholi; Mehul Mistri; Payal Nath; Chitra Ankleshwaria; Riddhi Bhavsar; Ratna Puri; Shubha Phadke; Frenny Sheth
Journal:  BMC Med Genet       Date:  2018-10-01       Impact factor: 2.103

9.  Gaucher disease in Syrian children: common mutations identification, and clinical futures.

Authors:  Diana Alasmar
Journal:  Ann Saudi Med       Date:  2015 Mar-Apr       Impact factor: 1.526

10.  Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes.

Authors:  Rafael Franco; Juan A Sánchez-Arias; Gemma Navarro; José L Lanciego
Journal:  Front Neuroanat       Date:  2018-06-28       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.